Advancing Accurate Quantification of Protein‐Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL‐2 as a Model System
ChemMedChem · 13.03.2026 · 21 (5)
DOI: 10.1002/cmdc.202500744 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 03.03.2026. Verfasst von Bircan Dinc und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Department of Biophysics, Bahcesehir University, Istanbul, 34734, Türkiye. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-bcl-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Accurate and reliable quantification of protein–ligand energetics at the screening stage is often complicated by ligand aggregation, hydrophobicity‐driven artifacts, and the need for cosolvents. Here, differential scanning calorimetry (DSC) as a quantitative, label‐free screening method is evaluated using BCL‐2 as a model oncogenic target. Nine inhibitors (i.e., venetoclax, navitoclax; and seven previously prioritized BCL‐2 hit inhibitors by our research group) are profiled across solvent systems, including neat DMSO, 10% DMSO, and a ternary matrix (S3: 10% DMSO, 90% sulfobutylether‐β‐cyclodextrin (SBE‐β‐CD) in saline). DSC yielded thermal transition temperatures and thermodynamic parameters ( ΔH , ΔG ) that enabled ranking of binding strength. Solubility challenges are addressed by S3, which improved thermal signal quality. Comparisons with time‐resolved fluorescence energy transfer (TR‐FRET) analysis, in vitro assays, and MM/GBSA binding free energy results confirmed DSC's accuracy in detecting binding energetics. Collectively, these results position DSC as a robust, material‐efficient tool for thermodynamic screening of BCL‐2 ligands and other poorly soluble compounds, and as a practical complement to isothermal titration calorimetry when solubility or kinetic limitations prevail.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Department of Biophysics, Bahcesehir University, Istanbul, 34734, Türkiye.
- Department of Physical Chemistry, Istanbul Technical University, Istanbul, 34469, Türkiye.
- Department of Chemistry, Capodistrian Athens University, Zographou, Athens, 15771, Greece.
- Molecular Therapy Lab, Department of Pharmaceutical Chemistry, School of Pharmacy, Bahcesehir University, Istanbul, 34353, Türkiye.
- Lab for Innovative Drugs (Lab4IND), Computational Drug Design Center (HİTMER), Bahçeşehir University, Istanbul, 34734, Türkiye.
- Quantitative System Biology Lab, Faculty of Medicine, Biruni University, Istanbul, 34015, Türkiye.
ORCID-Profile: Bircan Dinc, Berna Dogan, Thomas Mavromoustakos, Serdar Durdağı
Zitieren
APA
Dinc, B., Dogan, B., Mavromoustakos, T., & Durdağı, S. (2026). Advancing Accurate Quantification of Protein‐Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL‐2 as a Model System. ChemMedChem, 21(5). https://doi.org/10.1002/cmdc.202500744
Vancouver
Dinc B, Dogan B, Mavromoustakos T, Durdağı S. Advancing Accurate Quantification of Protein‐Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL‐2 as a Model System. ChemMedChem. 2026;21(5). doi:10.1002/cmdc.202500744
BibTeX
@article{Dinc2026,
author = {Dinc, Bircan and Dogan, Berna and Mavromoustakos, Thomas and Durdağı, Serdar},
title = {Advancing Accurate Quantification of Protein‐Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL‐2 as a Model System},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {5},
doi = {10.1002/cmdc.202500744}
}
EUVIMED